Close

Registration is free and only takes a moment. If you have already registered, please log in now.

Create Account
Forgot your password?
Log In
  • Links
  • Publisher Full Text
  • Authors
  • Margolin K
  • MESH
  • Antineoplastic Agents, Alkylating
  • Dacarbazine
  • Female
  • Humans
  • Imidazoles
  • Male
  • Melanoma
  • Oximes

Unbound MEDLINE

BRAF inhibition and beyond in advanced melanoma.

Links

  • Publisher Full Text

    • Authors

    Margolin K

    Institution

    Seattle Cancer Care Alliance, Seattle, WA 98109, USA. kmargoli@seattlecca.org

    Source

    Lancet 380:9839 2012 Jul 28 pg 320-2

    MeSH

    Antineoplastic Agents, Alkylating
    Dacarbazine
    Female
    Humans
    Imidazoles
    Male
    Melanoma
    Oximes

    Pub Type(s)

    Comment
    Journal Article

    Language

    eng

    PubMed ID

    22735383

    Related Citations

    • Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial.
    • Temozolomide for advanced, metastatic melanoma.
    • [Dacarbazine: deticene].
    • Temozolomide as prophylaxis for melanoma brain metastases.
    • Treatment of brain metastases of malignant melanoma with temozolomide.
    • Bcl-2 antisense (oblimersen sodium) plus dacarbazine in patients with advanced melanoma: the Oblimersen Melanoma Study Group.
    • Re-evaluating the role of dacarbazine in metastatic melanoma: what have we learned in 30 years?
    • [Dacarbazine].
    More
    unbound logo
    • Home »
    • Contact Us »
    • Help »
    • Privacy / Disclaimer »
    • Terms of Service »
    • Log In »
    • twitter
    • facebook
    © 2000–2013 Unbound Medicine, Inc. All rights reserved